Filtros de búsqueda

Lista de obras de Robert C. Bast

10th Biennial Helene Harris Memorial Trust Meeting

scientific article published on 01 March 2006

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

artículo científico publicado en 2001

395 POSTER CpG island methylator phenotype (CIMP): a novel biomaker to predict new therapy for breast cancer

4-HPR modulates gene expression in ovarian cells

artículo científico

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

artículo científico publicado en 1991

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

artículo científico publicado en 2019

801 ABSENCE OF COMMON ALL ANTIGEN ON NORMAL PLURIPOTENTIAL MYELOID, ERYTHROID AND GRANULOCYTE PROGENITORS

A 2-Stage Ovarian Cancer Screening Strategy Using the Risk of Ovarian Cancer Algorithm (ROCA) Identifies Early-Stage Incident Cancers and Demonstrates High Positive Predictive Value

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value

artículo científico publicado en 2013

A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies

artículo científico publicado en 2010

A Comparison of Immunohistochemistry, Two-Color Immunofluorescence, and Flow Cytometry with Cell Sorting for the Detection of Micrometastatic Breast Cancer in the Bone Marrow

scientific article published on 01 February 1996

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.

artículo científico publicado en 2016

A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells

artículo científico publicado en 2005

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

artículo científico publicado en 2011

A genetically defined model for human ovarian cancer

artículo científico publicado en 2004

A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer

artículo científico publicado en 2011

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care

artículo científico publicado en 2014

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

artículo científico publicado en 2009

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

artículo científico publicado en 2008

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β

artículo científico publicado en 2018

A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.

artículo científico publicado en 2012

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

artículo científico publicado en 1983

A study of the NB/70K and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients

article

ALTERED IMMUNOLOGIC RECONSTITUTION AFTER STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW SUPPORT

scientific article published on 01 July 1988

ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7

artículo científico publicado en 2014

ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins

artículo científico publicado en 2009

ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.

artículo científico publicado en 2015

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers

artículo científico publicado en 2003

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

scientific article published on 01 June 2000

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

artículo científico publicado en 2006

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

artículo científico publicado en 1982

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

artículo científico publicado en 2003

Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors

scientific article published on 01 August 1981

Abstract 1151: IL-8, VEGF and IGF-1 play the important role in ARHI mediated-tumor dormancy in ovarian cancer

Abstract 2311: NDN, an imprinted tumor suppressor gene inhibits ovarian cancer cell growth and motility and is downregulated by genetic and epigenetic mechanisms

article

Abstract 2838: TP53 autoantibody can detect CA125 screen negative ovarian cancer cases and can be elevated prior to CA125 in preclinical ovarian cancer

Abstract 3032: A novel compound ARN-3236 inhibits SIK2 and sensitizes ovarian cancer to paclitaxel

Abstract 3456: MUC16/CA125, TNFα and IFNγ are co-expressed in malignant gynecologic neoplasms

Abstract 3473: Intra-person and inter-person biomarker variation for modeling longitudinal values of ovarian cancer early detection biomarkers

Abstract 3495: Multiplexed detection of early-stage ovarian cancer biomarkers using a microfluidic bead-based immunosensor

Abstract 3659: DIRAS1 and DIRAS2 are novel ovarian cancer tumor suppressors that regulate cell growth, motility and autophagy

Abstract 3762: Downregulation of TRPC3 enhances sensitivity to cisplatin and inhibits motility in epithelial ovarian cancer

Abstract 3827: Histone methytransferase SMYD3 promotes invasion in ovarian carcinoma spheroids

Abstract 4028: ARHI plays a critical role in ovarian cancer tumor dormancy by inhibition of angiogenesis switch

Abstract 438: Development of an autoantibody panel that reflects disease pathogenesis in ovarian cancer

article

Abstract 4670: Combinations of kinase siRNAs potentiates paclitaxel sensitivity in ovarian cancer

Abstract 4766: Follicle stimulating hormone (FSH) inhibits apoptosis in ovarian cancer cell through regulating OCT4 stem cell signal pathway

Abstract 4987: IL8, VEGF and IGF-1 rescue ovarian cancer cells undergoing ARHI-mediated- autophagic cell death

Abstract 5105: The imprinted tumor suppressor gene NDN inhibits cell motility in ovarian cancer by reactivating FAK and RhoA

article

Abstract 749: Highly potent and orally available SIK2 inhibitors block growth of human ovarian cancer cells in culture and xenografts

article

Abstract AS12: Integrating genomics, transcriptomics, and proteomics for the discovery of novel biomarkers to complement CA125 in ovarian cancer early detection

Abstract LB-119: Single-cell live imaging of paclitaxel-resistant cancer cell generation

article by Na Niu et al published 15 July 2016 in Cancer Research

Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages.

artículo científico publicado en 1974

Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers

artículo científico publicado en 2003

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

artículo científico publicado en 2014

Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.

artículo científico publicado en 1998

Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer.

artículo científico publicado en 1994

Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

article

Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.

artículo científico publicado en 2016

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

artículo científico publicado en 2007

Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support

scientific article published on 01 June 1994

Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression.

artículo científico publicado en 2019

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma

artículo científico publicado en 1988

Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation

artículo científico publicado en 2004

Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders

scientific article published on 18 May 2020

Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms

scientific article published on 01 January 2000

Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.

artículo científico publicado en 2006

Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185

artículo científico publicado en 1993

Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.

artículo científico publicado en 1986

Antigenic heterogeneity in human ovarian cancer

artículo científico publicado en 1990

Antigenic heterogeneity in human ovarian cancer

Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma

artículo científico publicado el 1 de marzo de 1975

Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma

artículo científico publicado el 1 de marzo de 1975

Application of Monoclonal Antibodies to Autologous Bone Marrow Transplantation

article

Aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes.

artículo científico publicado en 1974

Aryl hydrocarbon (benzo(alpha)pyrene) hydroxylase in guinea pig peritoneal macrophages: benz(alpha)anthracene-induced increase of enzyme activity in vivo and in cell culture

artículo científico publicado el 1 de agosto de 1973

Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in guinea pig lymphoid tissue.

artículo científico publicado en 1981

Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

artículo científico publicado en 2012

BCG and cancer

artículo científico publicado en 1974

BCG and cancer (first of two parts).

artículo científico publicado en 1974

Biochemistry and Biology of ARHI (DIRAS3), an Imprinted Tumor Suppressor Gene Whose Expression Is Lost in Ovarian and Breast Cancers

article

Biology and therapy with biologic agents in gynecologic cancer.

artículo científico publicado en 1992

Biomarkers and Strategies for Early Detection of Ovarian Cancer

scientific article published on 13 October 2020

Biomarkers for ovarian cancer: New technologies and targets to address persistently unmet needs

artículo científico publicado el 3 de noviembre de 2011

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue

artículo científico publicado en 2004

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique

artículo científico publicado en 1996

Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature ⬇️

artículo científico publicado el 1 de agosto de 1982

CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients

article

CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary

artículo científico

CA 125 for the monitoring of ovarian carcinoma during primary therapy

artículo científico publicado en 1987

CA 125 in ovarian cancer: advances and controversy.

artículo científico publicado en 1998

CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer

artículo científico publicado en 1990

CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation

artículo científico publicado en 1989

CA 125 serum levels correlate with second-look operations among ovarian cancer patients: A prospective multi-institutional study

CA 125: the past and the future

artículo científico publicado en 1998

CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.

artículo científico publicado en 2013

CA125 antigen levels in obstetric and gynecologic patients

artículo científico publicado en 1984

CA125/MUC16 is dispensable for mouse development and reproduction

artículo científico publicado en 2009

CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis

artículo científico publicado en 2015

Carcinoma of the Pancreas

article

Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CT

scientific article published on 31 August 2018

Cell Origins of High-Grade Serous Ovarian Cancer

Cell growth regulation in epithelial ovarian cancer.

artículo científico publicado en 1993

Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells

scientific article published on 01 October 1998

Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.

artículo científico publicado en 1996

Characterization of the ARHI Tumor-Suppressor as a Target for Gene Therapy in Ovarian Cancer*

article

Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.

artículo científico publicado en 1986

Chemotherapy: A new standard combination for recurrent ovarian cancer?

artículo científico publicado en 2010

Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.

artículo científico publicado en 1985

Clinical Applications of Monoclonal Antibodies in Acute Leukemia

article

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers

artículo científico publicado en 2015

Clinical and laboratory directions for ovarian cancer research

artículo científico publicado en 1994

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors

artículo científico publicado en 1987

Clinical application of oxaliplatin in epithelial ovarian cancer.

artículo científico publicado en 2006

Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.

artículo científico publicado en 2007

Clinically relevant microRNAs in ovarian cancer

artículo científico publicado en 2014

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation

artículo científico publicado en 1992

Co-expression of human cancer-associated epitopes on mucin molecules

artículo científico publicado en 1987

Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells

artículo científico publicado en 2016

Coexpression of different antigenic markers on moieties that bear CA 125 determinants

artículo científico publicado en 1991

Coexpression of the HER-2 Gene Product, pl85HER-2, and Epidermal Growth Factor Receptor, pl70EGF-R, on Epithelial Ovarian Cancers and Normal Tissues

article

Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer

artículo científico

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

artículo científico publicado en 1999

Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement

artículo científico publicado en 1987

Combined use of biomarkers for detection of ovarian cancer in high-risk women

artículo científico publicado en 2010

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

artículo científico publicado en 2007

Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen

artículo científico publicado en 1992

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

artículo científico publicado en 2010

Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line ⬇️

artículo científico publicado el 15 de julio de 1983

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer

artículo científico publicado en 2019

Conquering Cancer in Our Lifetime: New Diagnostic and Therapeutic Trends

artículo científico publicado en 2012

Constitutive Production of Macrophage Colony-Stimulating Factor and Interleukin-6 by Human Ovarian Surface Epithelial Cells

artículo científico publicado en 1993

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines

artículo científico publicado en 1989

Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes

artículo científico publicado en 1983

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

scientific article published on 01 October 1991

Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium.

artículo científico publicado en 1994

Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

scientific article published on 01 September 2020

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

artículo científico publicado en 2007

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

artículo científico publicado en 2018

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

article

Current state of biomarker development for clinical application in epithelial ovarian cancer

artículo científico publicado en 2009

Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer

artículo científico publicado el 1 de julio de 1971

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

artículo científico publicado en 2011

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells ⬇️

artículo científico publicado el 1 de junio de 1991

DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters

scientific article published on 01 December 2019

DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells

artículo científico publicado en 2014

DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.

artículo científico publicado en 2019

DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy

artículo científico publicado en 2022

Dasatinib induces autophagic cell death in human ovarian cancer

artículo científico publicado en 2010

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy

artículo científico publicado en 2011

Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.

artículo científico publicado en 1999

Detection of a novel marker in the bronchial secretions of patients with non-small cell lung cancer using the 4B5 monoclonal antibody

artículo científico publicado el 15 de junio de 1992

Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology

artículo científico publicado en 1990

Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy

scientific article published on 01 December 1995

Determination of proliferation index in advanced ovarian cancer using quantitative image analysis

artículo científico publicado en 1993

Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis

artículo científico publicado en 1994

Development of a multimarker assay for early detection of ovarian cancer

artículo científico publicado en 2010

Development of an assay for aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes ⬇️

artículo científico publicado el 1 de junio de 1976

Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers

artículo científico publicado en 2012

Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3

artículo científico publicado en 1993

Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas

artículo científico publicado en 1994

Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines

artículo científico publicado en 1989

Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer

artículo científico publicado en 2012

Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo

artículo científico publicado en 2015

Early Detection of Ovarian Cancer

article

Early detection of ovarian cancer

artículo científico publicado en 2008

Early detection of ovarian cancer.

artículo científico publicado en 2007

Early detection of ovarian cancer: promise and reality

artículo científico publicado en 2002

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

artículo científico publicado en 1988

Elevated serum concentrations of CA-125 in patients with advanced endometriosis

artículo científico publicado en 1986

Elevation of CA-125 prior to recurrence of ovarian cancer

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

artículo científico publicado en 2017

Elevation of multiple serum markers in patients with stage I ovarian cancer.

artículo científico publicado en 1993

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

artículo científico publicado en 1985

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

article

Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement

artículo científico publicado en 1985

Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres

artículo científico publicado en 1991

Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates

scientific article published on 01 March 1986

Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition

scientific article published on 02 June 2020

Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement ⬇️

artículo científico publicado el 1 de marzo de 1983

Elimination of leukemic cells from rat bone marrow using antibody and complement

artículo científico publicado en 1981

Elimination of malignant clonogenic breast cancer cells from human bone marrow

artículo científico publicado en 1989

Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.

artículo científico publicado en 1985

Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells

artículo científico publicado en 2013

Enhanced arachidonic acid lipoxygenation by K562 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate

scientific article published on 01 January 1983

Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo

artículo científico publicado en 2016

Epidermal growth factor receptor expression in normal and malignant endometrium

artículo científico publicado en 1989

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer

artículo científico publicado en 1991

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

artículo científico publicado en 1991

Epigenetic regulation of ARHI in breast and ovarian cancer cells

artículo científico publicado en 2003

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

artículo científico publicado en 2003

Expression and amplification of the HER-2/ neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines

scientific article published on 01 September 1991

Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma

artículo científico publicado en 2013

Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancer

artículo científico publicado en 2004

Expression of cell regulatory proteins in ovarian borderline tumors

scientific article published on 01 May 1996

Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina

artículo científico publicado en 1990

Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms ⬇️

artículo científico publicado el 15 de noviembre de 1983

Expression of p16 induces transcriptional downregulation of the RB gene

artículo científico publicado en 1998

Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)

scientific article published on 01 March 1999

Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma

artículo científico publicado en 1996

Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival

scientific article published on 01 October 2004

FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization

artículo científico publicado en 2011

FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

artículo científico publicado en 2013

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer

artículo científico publicado en 1992

Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents

artículo científico publicado en 2002

Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway

artículo científico publicado en 2013

Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer

artículo científico publicado en 2000

Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics

artículo científico publicado en 2001

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

artículo científico publicado en 2015

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

article

General keynote: molecular therapeutics and pharmocogenomics

artículo científico publicado en 2003

Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling

artículo científico publicado en 2005

Genetic analysis of early- versus late-stage ovarian tumors.

artículo científico publicado en 2001

Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI.

artículo científico publicado en 2001

Growth regulation and transformation of ovarian epithelium

artículo científico publicado en 1993

Guidelines for the use and interpretation of assays for monitoring autophagy

artículo científico publicado en 2012

Gynecologic tumor markers

artículo científico

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

artículo científico publicado en 2006

HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways

artículo científico publicado en 2005

Ha-ras polymorphisms in epithelial ovarian cancer

artículo científico publicado en 1992

Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis

artículo científico publicado en 1997

Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity

artículo científico publicado en 2001

Heterogeneity of antigen expression in advanced epithelial ovarian cancer

artículo científico publicado en 1990

Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells

scientific article published on 01 January 1989

Heterogeneity of the cellular immune response. I. Kinetics of lymphocyte stimulation during sensitization and recovery from tolerance

artículo científico publicado en 1971

Heterogeneity of the cellular immune response. II. The role of adjuvant, lymphocyte stimulation in cutaneous basophil hypersensitivity

artículo científico publicado en 1971

High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity

artículo científico

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

scientific article published on 01 September 1990

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

artículo científico publicado en 1993

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

artículo científico publicado en 1986

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

scientific article published on 01 September 1988

High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support

scientific article published on 01 January 1989

High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer

artículo científico publicado en 2001

Homologous and heterologous desensitization of proto-oncogene cfos expression in murine peritoneal macrophages

article

How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above

artículo científico publicado en 2007

How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?

artículo científico publicado en 2015

Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer

artículo científico publicado en 2019

IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming

artículo científico publicado en 2021

Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer

artículo científico publicado en 1987

Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop

artículo científico publicado en 1996

Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential

scientific article published on 01 April 1989

Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels

artículo científico publicado en 1989

Immunologic unresponsiveness in the adult guinea pig. IV. Induction of unresponsiveness with aggregated serum proteins.

artículo científico publicado en 1969

Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation

artículo científico publicado en 1991

Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types

scientific article published on 01 January 1983

Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation

scientific article published on 01 January 1990

Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells

artículo científico publicado en 1980

Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity ⬇️

artículo científico publicado el 1 de noviembre de 1979

Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells

artículo científico publicado en 2010

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation

artículo científico publicado en 2008

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In Vivo Optical Detection and Spectral Triangulation of Carbon Nanotubes

artículo científico publicado en 2017

In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer

artículo científico publicado en 2005

In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia

artículo científico publicado en 1983

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice

artículo científico publicado en 2020

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

artículo científico publicado en 1991

Individualized care for patients with cancer - a work in progress

artículo científico publicado en 2004

Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models

artículo científico publicado en 2016

Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment

artículo científico publicado en 2010

Induction of tumor immunity by intratumoral chemotherapy

artículo científico publicado en 1976

Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody

artículo científico publicado en 1988

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

artículo científico publicado en 2003

Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells

artículo científico publicado en 2000

Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas ⬇️

artículo científico publicado el 1 de julio de 1984

Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum

artículo científico publicado en 1985

Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.

artículo científico publicado en 1983

Is OVX1 a suitable marker for endometrial cancer?

artículo científico publicado en 1997

Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells

artículo científico publicado en 2006

Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer

artículo científico publicado en 2003

Local Antitumor Activity of a Primary and an Anamnestic Response to a Syngeneic Guinea Pig Hepatoma ⬇️

artículo científico publicado el 1 de octubre de 1975

Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells

artículo científico publicado en 2017

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

artículo científico publicado en 2003

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

artículo científico publicado en 2008

Low-grade serous carcinoma: new concepts and emerging therapies.

artículo científico

Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer

artículo científico publicado en 1984

Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells

artículo científico publicado en 1999

Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer

artículo científico publicado en 2006

Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase

artículo científico publicado en 2000

MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma

artículo científico publicado en 2009

MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse

scientific journal article

Malignant transformation of ovarian epithelium

artículo científico publicado en 1992

Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells

artículo científico publicado en 2003

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

artículo científico publicado en 2012

Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy

artículo científico publicado en 2012

Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel

artículo científico publicado en 2011

Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer

artículo científico publicado en 2012

Molecular approaches to prevention and detection of epithelial ovarian cancer.

artículo científico publicado en 1995

Molecular genetic features of ovarian cancer.

artículo científico publicado en 1996

Monitoring growth of human ovarian carcinoma with a radioimmunoassay for antigen(s) defined by a murine monoclonal antibody (0C125)

article published in 1983

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen

article

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas ⬇️

artículo científico publicado el 1 de marzo de 1984

Monocyte chemotaxis mediated by f-MET-LEU-PHE (fMLP) conjugated with monoclonal anti-bodies against human ovarian carcinoma

scholarly article by R. Obrist et al published January 1982 in International Journal of Immunopharmacology

Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma

article

More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis.

artículo científico publicado en 2011

Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture

artículo científico publicado el 1 de agosto de 1971

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women

scientific article published on 17 July 2020

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

artículo científico publicado en 1994

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer

artículo científico publicado en 1993

Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas

artículo científico publicado en 1994

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.

artículo científico publicado en 1993

NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms

artículo científico publicado en 2015

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

artículo científico publicado en 1999

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

artículo científico publicado en 2008

Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization ⬇️

artículo científico publicado el 1 de mayo de 1976

New approach to serotherapy of human ovarian carcinoma

New tumor markers: CA125 and beyond.

artículo científico publicado en 2005

Novel Approaches to Ovarian Cancer Screening

artículo científico publicado en 2019

OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders

scientific article published on 01 July 1998

OVX1 radioimmunoassay results are dependent on the method of sample collection and storage

OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal

scientific article published on 01 December 2001

Oncogenes in ovarian cancer

artículo científico publicado en 1992

Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.

artículo científico publicado en 2007

Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.

artículo científico publicado en 2019

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

artículo científico publicado en 2011

Ovarian cancer identified through screening with serum markers but not by pelvic imaging

scientific article published on 01 November 1999

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

artículo científico publicado en 1995

Overexpression and mutation of p53 in endometrial carcinoma

artículo científico publicado en 1992

Overexpression and mutation of p53 in epithelial ovarian cancer

artículo científico publicado en 1991

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

artículo científico publicado en 1991

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

artículo científico publicado en 2003

Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression

artículo científico publicado en 1994

Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas

artículo científico publicado en 1994

Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

artículo científico publicado en 2018

Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis

artículo científico publicado en 2003

Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells

artículo científico publicado en 2012

Pathogenesis of Ovarian Cancers ⬇️

artículo científico publicado el 1 de julio de 1994

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

artículo científico publicado en 2005

Perception of risk, cancer worry, anxiety, and acceptability of screening among low-risk women undergoing ovarian cancer screening with the risk of ovarian cancer algorithm

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

artículo científico publicado en 2012

Personalizing therapy for ovarian cancer: BRCAness and beyond

artículo científico publicado en 2010

Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen

scientific article published on 01 January 1989

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

artículo científico publicado en 2010

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

artículo científico publicado en 2010

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

artículo científico publicado en 2001

Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation

artículo científico publicado en 2001

Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model

artículo científico publicado en 1998

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

artículo científico publicado en 2011

Ploidy analysis of epithelial ovarian cancers using image cytometry

scientific article published on 01 January 1992

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models

artículo científico publicado en 2019

Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.

artículo científico publicado en 2011

Potential markers that complement expression of CA125 in epithelial ovarian cancer

artículo científico publicado en 2005

Potentially inappropriate medication use in older patients with breast and colorectal cancer.

artículo científico publicado en 2018

Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer

scientific article published on 19 February 2019

Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer

artículo científico publicado en 1985

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

artículo científico publicado en 2000

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.

artículo científico publicado en 2016

Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer

artículo científico publicado en 1996

Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer

artículo científico publicado en 1986

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

article

Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma

artículo científico publicado en 1990

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

artículo científico publicado en 2004

Preoperative serum tumor-associated antigen levels in women with pelvic masses

artículo científico publicado en 1990

Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatoma

artículo científico publicado en 1974

Prevention and early detection of ovarian cancer: mission impossible?

artículo científico publicado en 2007

Prevention of ovarian cancer: intraepithelial neoplasia.

artículo científico publicado en 2003

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

artículo científico publicado en 1999

Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care

artículo científico publicado en 2012

Progress in the management of gynecologic cancer: consensus summary statement

artículo científico publicado en 2003

Project Zero Delay: a process for accelerating the activation of cancer clinical trials

artículo científico publicado en 2009

Pros and cons of gynecologic tumor markers

artículo científico

Pros and cons of gynecologic tumor markers

article

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer

artículo científico publicado en 1992

Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer

artículo científico publicado en 1990

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer

artículo científico publicado en 2005

Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis

scientific article published on 19 February 2020

Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer

artículo científico publicado en 2011

Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

artículo científico publicado en 2011

Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model

artículo científico publicado en 2005

RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells.

artículo científico publicado en 2018

Radioiodinated antibody targeting of the HER-2/neu oncoprotein

artículo científico publicado en 1997

Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution

artículo científico publicado en 1999

Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel ⬇️

artículo científico publicado el 19 de enero de 2011

Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation

artículo científico publicado en 2003

Reactivity of a monoclonal antibody with human ovarian carcinoma

artículo científico publicado en 1981

Reactivity of epidermal growth factor receptor monoclonal antibodies with human uterine tissues

artículo científico publicado en 1989

Recombinant leukocyte alpha interferon in advanced ovarian carcinoma

artículo científico publicado en 1985

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

artículo científico publicado en 1997

Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway

article

Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

artículo científico publicado en 2012

Regression of Established Tumors and Induction of Tumor Immunity by Intratumor Chemotherapy ⬇️

artículo científico publicado el 1 de abril de 1976

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

artículo científico publicado en 1999

Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta

artículo científico publicado en 1995

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta

artículo científico publicado en 1992

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta

artículo científico publicado en 2001

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

artículo científico publicado en 1994

Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185.

artículo científico publicado en 1999

Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer

scientific article published on 18 September 2019

Reply to Davies et al

article

Reproducibility of SELDI Spectra Across Time and Laboratories

artículo científico publicado en 2011

Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2 ⬇️

artículo científico publicado el 1 de octubre de 1991

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

artículo científico publicado en 2015

Rethinking ovarian cancer: recommendations for improving outcomes

artículo científico publicado en 2011

Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening

artículo científico publicado en 2013

Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer ⬇️

artículo científico publicado el 1 de septiembre de 2003

Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells

artículo científico publicado en 2007

SCC antigen. Summary remarks

scientific article published on 01 January 1998

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

artículo científico publicado en 2010

SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters

scientific article published on 30 October 2019

Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche

scientific journal article

Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.

artículo científico publicado en 1993

Screening for ovarian cancer: imaging challenges and opportunities for improvement.

artículo científico publicado en 2017

Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma

scientific article published on 01 February 1994

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

artículo científico publicado en 2004

Serotherapy and Bone Marrow Transplantation

Serotherapy of ovarian cancer

artículo científico publicado en 1988

Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

artículo científico publicado en 2011

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

artículo científico publicado en 2010

Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer

scientific article published on 01 June 1993

Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.

artículo científico publicado en 2011

Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection

artículo científico publicado en 2019

Somatic activation of rasK gene in a human ovarian carcinoma

artículo científico publicado en 1984

Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.

artículo científico publicado en 2008

Specific keynote: chemoprevention of ovarian cancer: the journey begins

artículo científico publicado en 2003

Specific keynote: molecular therapeutics in ovarian cancer

artículo científico publicado en 2003

Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 Workshop

artículo científico publicado en 1996

Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells

artículo científico publicado en 1980

Spectral differences between epitopes in the cronomes of salivary CA130 and CA125

scientific article published on 01 July 1995

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

scientific article published on 01 September 1993

Src family kinases and paclitaxel sensitivity

artículo científico publicado en 2011

Stanniocalcin 1 and ovarian tumorigenesis

artículo científico publicado en 2010

Status of Tumor Markers in Ovarian Cancer Screening ⬇️

artículo científico publicado el 15 de mayo de 2003

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α

artículo científico publicado en 1992

Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3 ⬇️

artículo científico publicado el 1 de septiembre de 1992

Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.

artículo científico publicado en 2005

Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines

artículo científico publicado en 1998

Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer

artículo científico publicado en 1991

Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2

artículo científico publicado en 2000

Targeting Aurora kinases in ovarian cancer

artículo científico publicado en 2006

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

artículo científico publicado en 2010

The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer

article

The National Cancer Institute Early Detection Research Network: Two Decades of Progress

artículo científico publicado en 2020

The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade

scientific article published on 23 February 2010

The biology of ovarian cancer

artículo científico publicado en 1993

The biology of ovarian cancer: new opportunities for translation

artículo científico publicado en 2009

The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis

artículo científico publicado en 2006

The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharide

artículo científico publicado en 1987

The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages.

artículo científico publicado en 1987

The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines

artículo científico publicado en 1993

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells

artículo científico publicado en 1992

The half-life of aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human blood monocytes

artículo científico publicado en 1976

The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice

artículo científico publicado en 2000

The origin of ovarian cancer

artículo científico publicado en 2012

The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression

artículo científico publicado en 1999

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

artículo científico publicado en 1994

The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction

artículo científico publicado en 1990

The role of biomarkers in the management of epithelial ovarian cancer

artículo científico publicado en 2017

The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis

artículo científico publicado en 2006

The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition

artículo científico publicado en 2003

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells

artículo científico publicado en 2011

The role of peptide growth factors in epithelial ovarian cancer.

artículo científico publicado en 1990

The role of tumor markers in gynecologic oncology.

artículo científico publicado en 1990

The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3‐induced dormant ovarian cancer xenografts

scientific article published on 08 January 2019

The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support

artículo científico publicado el 1 de junio de 1997

The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms

artículo científico publicado en 2013

The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

artículo científico publicado en 2008

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

artículo científico publicado en 2012

The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin

artículo científico publicado en 1994

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

artículo científico publicado en 2007

The use of tumor markers in the management of patients with gynecologic carcinomas

artículo científico publicado en 1992

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

artículo científico publicado en 2004

Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125

scientific article published on 01 January 1983

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

artículo científico publicado en 1995

Toward salivary-urinary chronosensitivity testing: chronomes of OVX1, M-CSF and CA130

artículo científico publicado en 1995

Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer

artículo científico publicado en 2006

Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression.

artículo científico publicado en 2016

Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression

artículo científico publicado en 1996

Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alpha

artículo científico publicado en 1994

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells ⬇️

artículo científico publicado el 1 de diciembre de 1994

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites

scientific article published on 01 July 1994

Translational crossroads for biomarkers

artículo científico publicado en 2005

Translational research--traffic on the bridge.

artículo científico publicado en 2001

Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes

artículo científico publicado en 1986

Tumor Suppressor Genes

article

Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination

scientific article published on 01 April 1988

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

artículo científico publicado en 1996

Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression

artículo científico publicado en 1993

Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.

scientific article published on 24 February 2016

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

artículo científico publicado en 2010

Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.

artículo científico publicado en 2018

Urinary levels of Bcl-2 are elevated in ovarian cancer patients

artículo científico publicado en 2008

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

artículo científico publicado en 2007

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx

scientific article published on 31 May 2019

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2016

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

artículo científico

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2015

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

artículo científico publicado en 2004

Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer

artículo científico publicado en 2006

Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

artículo científico publicado en 2008

Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer

artículo científico publicado en 2016

Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer

artículo científico publicado en 2016

Weight Loss Upregulates the Small GTPase DIRAS3 in Human White Adipose Progenitor Cells, Which Negatively Regulates Adipogenesis and Activates Autophagy via Akt-mTOR Inhibition

artículo científico publicado en 2016

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry

scientific article published on 01 July 1992

p53-Based Gene Therapy of Ovarian Cancer: Magic Bullet? ⬇️

artículo científico publicado el 1 de noviembre de 1995

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

artículo científico publicado en 2016

Guía para el uso y la interpretación de ensayos para el seguimiento de la autofagia (4ª edición)

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda